You have 9 free searches left this month | for more free features.

mRNA transcription

Showing 1 - 25 of 1,248

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Water and Electrolytes Content in HYpertension (WHYSKI) in SKIn

Recruiting
  • Hyperaldosteronism
  • +7 more
  • Skin Biopsy
  • Video-laparoscopic adrenalectomy
  • Padova, Italy
    Azienda Ospedale Università di Padova
Oct 23, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in United States

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • San Francisco, California
  • +5 more
Nov 1, 2023

Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345)

Recruiting
  • Respiratory Syncytial Virus
  • Birmingham, Alabama
  • +269 more
Jan 30, 2023

Seasonal Influenza Trial in Argentina, Australia, Colombia (mRNA-1010, Licensed quadrivalent inactivated seasonal influenza

Active, not recruiting
  • Seasonal Influenza
  • mRNA-1010
  • Licensed quadrivalent inactivated seasonal influenza vaccine
  • Buenos Aires, Argentina
  • +52 more
Sep 19, 2022

CNS Tumor, Solid Tumor Trial in Worldwide (Nivolumab and Entinostat)

Recruiting
  • CNS Tumor
  • Solid Tumor
  • Nivolumab and Entinostat
  • Randwick, New South Wales, Australia
  • +13 more
Nov 8, 2022

Postural Tachycardia Syndrome Trial in Nashville (NET mRNA level, Plasma catechols, Urine Catechols)

Enrolling by invitation
  • Postural Tachycardia Syndrome
  • NET mRNA level
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Sep 4, 2021

Knee Osteoarthritis Trial (SOLUGEL, Placebo)

Not yet recruiting
  • Knee Osteoarthritis
  • SOLUGEL
  • Placebo
  • (no location specified)
Apr 25, 2023

IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney

Active, not recruiting
  • Kidney Transplantation
  • anti-spike SARS-CoV-2 IgG
  • Prague, Czechia
    Institute for Clinical and Experimental Medicine
Dec 16, 2021

Kidney Transplant Recipient Trial in Phoenix, Jacksonville, Rochester (Janssen Ad26.CoV2.S Vaccine, Reduction in

Recruiting
  • Kidney Transplant Recipient
  • Janssen Ad26.CoV2.S Vaccine
  • +2 more
  • Phoenix, Arizona
  • +2 more
Jul 14, 2022

Seasonal Influenza Trial in Worldwide (mRNA-1010, Licensed quadrivalent inactivated seasonal influenza vaccine)

Recruiting
  • Seasonal Influenza
  • mRNA-1010
  • Licensed quadrivalent inactivated seasonal influenza vaccine
  • Athens, Alabama
  • +233 more
Sep 30, 2022

Platelet and Immune Response in Covid-19 Vaccine

Recruiting
  • SARS-CoV-2 Vaccination
    • Roma, Italy
      Sapienza University of Rome
    Dec 27, 2021

    Covid19, SARS-CoV-2 Trial in Worldwide (CVnCoV, Placebo, Authorized/licensed vaccines for preventing COVID-19 (AV))

    Completed
    • Covid19
    • SARS-CoV-2
    • CVnCoV
    • +2 more
    • Buenos Aires, Argentina
    • +45 more
    Jun 20, 2022

    Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +9 more
    • Biospecimen Collection
    • Electronic Health Record Review
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Oct 4, 2023

    Psychosis Trial in Sant Boi De Llobregat (Water aerobics, Metacognitive Training (MCT), Combined intervention)

    Recruiting
    • Psychosis
    • Water aerobics
    • +2 more
    • Sant Boi De Llobregat, Barcelona, Spain
      Parc Sanitari Sant Joan de Déu
    Jul 7, 2022

    Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Recruiting
    • Systemic Lupus Erythematosus
    • +2 more
    • Belimumab in SLE patients / Rituximab in RA patients
    • Monserrato, Cagliari, Italy
      Matteo Piga
    Dec 13, 2022

    Inflammatory Response, Pain, Postoperative, Nausea, Postoperative Trial in Aabenraa (Dexamethasone phosphate, Placebo)

    Recruiting
    • Inflammatory Response
    • +4 more
    • Dexamethasone phosphate
    • Placebo
    • Aabenraa, Denmark
      Gyn. Dept.;Aabenraa Hospital, Sygehus Sønderjylland
    Jul 11, 2022

    COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

    Not yet recruiting
    • COVID-19
    • Tozinameran
    • +3 more
    • Melbourne, Victoria, Australia
      Royal Children's Hospital, Murdoch Children's Research Institute
    Sep 14, 2022

    Coronavirus, Covid19, SARS-CoV-2 Trial in Panama city, Lima (CVnCoV 6 µg, CVnCoV 12 µg, Hepatitis A vaccine)

    Completed
    • Coronavirus
    • +3 more
    • CVnCoV 6 μg
    • +4 more
    • Panama city, Panama
    • +1 more
    Mar 9, 2022

    Effects of Lead Exposure on Ferroptosis Pathway

    Recruiting
    • Lead Poisoning
    • Neurotoxicity
    • Lead exposure
    • Yangzhou, Jiangsu, China
      Wenjing Zhao
    Jul 19, 2023

    Atopic Dermatitis Trial in Bangkok (Tape strips)

    Not yet recruiting
    • Atopic Dermatitis
    • Tape strips
    • Bangkok, Thailand
      Queen Sirikit National Institute of Child Health
    Nov 1, 2022

    Parkinson's Disease Trial in Novara (Probiotics, Placebo)

    Enrolling by invitation
    • Parkinson's Disease
    • Probiotics
    • Placebo
    • Novara, Italy
      Azienda Ospedaliero-Universitaria "Maggiore della Carità"
    Jun 9, 2022

    COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)

    Active, not recruiting
    • COVID-19
    • Tozinameran - Standard dose
    • +3 more
    • Melbourne, Victoria, Australia
      Royal Children's Hospital
    Aug 24, 2022

    Pumilio1 Expression, Sickle Cell Anemia, ß-thalassemia

    Not yet recruiting
    • Sickle Cell Disease, Beta Thalassemia Intermedia
    • RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
    • (no location specified)
    May 30, 2023

    miR-155 Expression in Episodic and Chronic Migraine

    Recruiting
    • Migraine
    • +3 more
      • Pavia, Italy
        IRCCS Mondino Foundation
      Jun 7, 2023

      Polycythemia; Familial, Erythrocytosis; Familial, VHL Gene Mutation Trial (Digoxin)

      Not yet recruiting
      • Polycythemia; Familial
      • +5 more
      • (no location specified)
      Feb 2, 2022